Skip to main content
Erschienen in: American Journal of Clinical Dermatology 6/2006

01.12.2006 | Original Research Article

Efficacy and Safety of Hyaluronic Acid in the Management of Acute Wounds

verfasst von: Dr Véronique Voinchet, Pascal Vasseur, Jérôme Kern

Erschienen in: American Journal of Clinical Dermatology | Ausgabe 6/2006

Einloggen, um Zugang zu erhalten

Abstract

Introduction: Hyaluronic acid (hyaluronan) is a key component of the extracellular matrix and is known to be involved in several mechanisms of the wound healing process. It has been shown to improve and accelerate the healing process of chronic wounds. This open-label study investigated whether application of hyaluronic acid could also improve the healing progression of acute wounds.
Methods: Forty-three patients with acute wounds, including trauma wounds, surgical sutures, burns, and dermabrasions, were included in the study. Hyaluronic acid (ialuset®) was applied either as a cream or as a dressing, and the progression and quality of healing were evaluated at each application for a maximum of nine applications.
Results: The mean surface area of the wounds decreased from 556 mm2 at baseline to 169 mm2 by the sixth evaluation, an average reduction of 70% in the surface area of the wounds. Complete healing occurred in 56% of cases by the sixth application. Little or no fibrin was observed in 91% of cases, and 84% of wounds showed little or no exudate. Both formulations of hyaluronic acid were well tolerated and were rated highly by nurses and patients for ease of use and treatment satisfaction.
Conclusion: Interpretation of the results of this open-label study is limited by the lack of a standard wound dressing as a comparator and by the varying types of wounds selected for inclusion. Nevertheless, the results of this study indicate that hyaluronic acid provides good healing of acute wounds and is well accepted by both patients and nurses.
Fußnoten
1
The use of trade names is for product identification purposes only and does not imply endorsement.
 
Literatur
1.
Zurück zum Zitat Brown JA. The role of hyaluronic acid in wound healing’s proliferative phase. J Wound Care 2004 Feb; 13 (2): 48-51PubMed Brown JA. The role of hyaluronic acid in wound healing’s proliferative phase. J Wound Care 2004 Feb; 13 (2): 48-51PubMed
2.
Zurück zum Zitat Chen WYJ, Abatangelo G. Functions of hyalmonan in wound repair. Wound Repair Regen 1999; 7: 79-89PubMedCrossRef Chen WYJ, Abatangelo G. Functions of hyalmonan in wound repair. Wound Repair Regen 1999; 7: 79-89PubMedCrossRef
3.
Zurück zum Zitat Weindl G, Schaller M, Schdfer-Korting M, et al. Hyaluronic acid in the treatment and prevention of skin diseases: molecular, biological, pharmaceutical and clinical aspects. Skin Pharmacol Physiol 2004; 17: 207-13PubMedCrossRef Weindl G, Schaller M, Schdfer-Korting M, et al. Hyaluronic acid in the treatment and prevention of skin diseases: molecular, biological, pharmaceutical and clinical aspects. Skin Pharmacol Physiol 2004; 17: 207-13PubMedCrossRef
4.
Zurück zum Zitat Price RD, Myers S, Leigh IM, et al. The role of hyaluronic acid in wound healing: assessment of clinical evidence. Am J Clin Dermatol 2005; 6 (6): 393-402PubMedCrossRef Price RD, Myers S, Leigh IM, et al. The role of hyaluronic acid in wound healing: assessment of clinical evidence. Am J Clin Dermatol 2005; 6 (6): 393-402PubMedCrossRef
5.
Zurück zum Zitat Longaker MT, Chin ES, Adzick S, et al. Studies in fetal wound healing: prolonged presence of hyaluronic acid characterizes fetal wound fluid. Ann Surg 1991; 213: 292-6PubMedCrossRef Longaker MT, Chin ES, Adzick S, et al. Studies in fetal wound healing: prolonged presence of hyaluronic acid characterizes fetal wound fluid. Ann Surg 1991; 213: 292-6PubMedCrossRef
6.
Zurück zum Zitat Ferguson MWJ, O’Kane S. Scar-free healing: from embryonic mechanisms to adult therapeutic intervention. Philos Trans R Soc Lond B Biol Sci 2004; 359: 839-50PubMedCrossRef Ferguson MWJ, O’Kane S. Scar-free healing: from embryonic mechanisms to adult therapeutic intervention. Philos Trans R Soc Lond B Biol Sci 2004; 359: 839-50PubMedCrossRef
7.
Zurück zum Zitat Ortonne JP. A controlled study of the activity of hyaluronic acid in the treatment of venous leg ulcers. J Dermatol Treat 1996; 7: 75-81CrossRef Ortonne JP. A controlled study of the activity of hyaluronic acid in the treatment of venous leg ulcers. J Dermatol Treat 1996; 7: 75-81CrossRef
8.
Zurück zum Zitat Bruni T. Evaluation de l’activité et de la tolérance locale de Iasulet© crè;me et compresse dans le traitement des ulcè;res des membres inférieurs. Dossier d’enregistrement. Laboratoires Genévrier, Sophia-Antipolis, France, 1994 Bruni T. Evaluation de l’activité et de la tolérance locale de Iasulet© crè;me et compresse dans le traitement des ulcè;res des membres inférieurs. Dossier d’enregistrement. Laboratoires Genévrier, Sophia-Antipolis, France, 1994
9.
Zurück zum Zitat Bonnetblanc JM. Propriétés pharmacologiques de l’acide hyalmonique. Ann Dermatol Venereol 2001 Mar; Suppl.: 9-12 Bonnetblanc JM. Propriétés pharmacologiques de l’acide hyalmonique. Ann Dermatol Venereol 2001 Mar; Suppl.: 9-12
10.
Zurück zum Zitat Navsaria H. L’acide hyaluronique, matériel biotechnologique. Ann Dermatol Venereol 2002; 129: 1227-30PubMed Navsaria H. L’acide hyaluronique, matériel biotechnologique. Ann Dermatol Venereol 2002; 129: 1227-30PubMed
11.
Zurück zum Zitat Trabucchi E, Pallotta S, Morivi M, et al. Low molecular weight hyalmonic acid prevents oxygen free radical damage to granulation tissue during wound healing. Int J Tissue React 2002; 24 (2): 65-71PubMed Trabucchi E, Pallotta S, Morivi M, et al. Low molecular weight hyalmonic acid prevents oxygen free radical damage to granulation tissue during wound healing. Int J Tissue React 2002; 24 (2): 65-71PubMed
12.
Zurück zum Zitat Liguori V, Guillemin C, Pesce GF, et al. Double-blind, randomized clinical study comparing hyaluronic acid cream to placebo in patients treated with radiotherapy. Radiother Oncol 1997 Feb; 42 (2): 155-61PubMedCrossRef Liguori V, Guillemin C, Pesce GF, et al. Double-blind, randomized clinical study comparing hyaluronic acid cream to placebo in patients treated with radiotherapy. Radiother Oncol 1997 Feb; 42 (2): 155-61PubMedCrossRef
13.
Zurück zum Zitat Koller J. Topical treatment of partial thickness burns by silver sulfadiazine plus hyalmonic acid compared to silver sulfadiazine alone: a double-blind, clinical study. Drugs Exp Clin Res 2004; 30 (5/6): 183-90PubMed Koller J. Topical treatment of partial thickness burns by silver sulfadiazine plus hyalmonic acid compared to silver sulfadiazine alone: a double-blind, clinical study. Drugs Exp Clin Res 2004; 30 (5/6): 183-90PubMed
14.
Zurück zum Zitat Costagliola M, Agrosi M. Second-degree burns: a comparative, multicenter, randomized trial of hyalmonic acid plus silver sulfadiazine vs silver sulfadiazine alone. Curr Med Res Opin 2005 Aug; 21 (8): 1235-40PubMedCrossRef Costagliola M, Agrosi M. Second-degree burns: a comparative, multicenter, randomized trial of hyalmonic acid plus silver sulfadiazine vs silver sulfadiazine alone. Curr Med Res Opin 2005 Aug; 21 (8): 1235-40PubMedCrossRef
15.
Zurück zum Zitat Chen WY, Abatangelo G. Functions of hyaluronan in wound repair. Wound Repair Regen 1999 Mar-Apr; 7 (2): 79-89 Chen WY, Abatangelo G. Functions of hyaluronan in wound repair. Wound Repair Regen 1999 Mar-Apr; 7 (2): 79-89
Metadaten
Titel
Efficacy and Safety of Hyaluronic Acid in the Management of Acute Wounds
verfasst von
Dr Véronique Voinchet
Pascal Vasseur
Jérôme Kern
Publikationsdatum
01.12.2006
Verlag
Springer International Publishing
Erschienen in
American Journal of Clinical Dermatology / Ausgabe 6/2006
Print ISSN: 1175-0561
Elektronische ISSN: 1179-1888
DOI
https://doi.org/10.2165/00128071-200607060-00003

Weitere Artikel der Ausgabe 6/2006

American Journal of Clinical Dermatology 6/2006 Zur Ausgabe

Images in Dermatopathology

Dermal Dendrocyte Ballooning

Acknowledgments

Acknowledgment

Leitlinien kompakt für die Dermatologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Studienlage spricht für Isotretinoin zur Rosazea-Therapie

23.05.2024 Rosazea Nachrichten

Isotretinoin wird off-label zur Behandlung von Rosazea eingesetzt. Wie solide die Evidenz dafür ist, wurde jetzt in einem systematischen Review überprüft.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Riesenzellarteriitis: 15% der Patienten sind von okkulter Form betroffen

16.05.2024 Riesenzellarteriitis Nachrichten

In einer retrospektiven Untersuchung haben Forschende aus Belgien und den Niederlanden die okkulte Form der Riesenzellarteriitis genauer unter die Lupe genommen. In puncto Therapie und Rezidivraten stellten sie keinen sehr großen Unterschied zu Erkrankten mit kranialen Symptomen fest.

Update Dermatologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.